Schneider CA - Search Results

1

Prognostic impact of electrocardiographic signs in patients with Type 2 diabetes and cardiovascular disease: results from the PROactive study.

Pfister R, Cairns R, Erdmann E, Schneider CA; PROactive investigators. Pfister R, et al. Among authors: schneider ca. Diabet Med. 2011 Oct;28(10):1206-12. doi: 10.1111/j.1464-5491.2011.03281.x. Diabet Med. 2011. PMID: 21388447 Free article.

2

An increase in HbA1c after percutaneous coronary intervention raises the risk for restenosis in patients without Type 2 diabetes mellitus.

Diedrichs H, Pfister R, Hagemeister J, Müller-Ehmsen J, Frank KF, Höpp HW, Erdmann E, Schneider CA. Diedrichs H, et al. Among authors: schneider ca. Diabet Med. 2008 Feb;25(2):228-31. doi: 10.1111/j.1464-5491.2007.02320.x. Epub 2007 Nov 19. Diabet Med. 2008. PMID: 18028437

3

[Predictive value of NT-pro-BNP for the non-cardiologist. A study on 573 hospitalized patients with cardiovascular disease].

Pfister R, Tan D, Thekkanal J, Erdmann E, Schneider CA. Pfister R, et al. Among authors: schneider ca. Dtsch Med Wochenschr. 2008 Mar;133(12):564-9. doi: 10.1055/s-2008-1067282. Dtsch Med Wochenschr. 2008. PMID: 18335382 German.

4

Natriuretic peptides BNP and NT-pro-BNP: established laboratory markers in clinical practice or just perspectives?

Pfister R, Schneider CA. Pfister R, et al. Among authors: schneider ca. Clin Chim Acta. 2004 Nov;349(1-2):25-38. doi: 10.1016/j.cccn.2004.06.018. Clin Chim Acta. 2004. PMID: 15469852 Review.

5

NT-pro-BNP measured at discharge predicts outcome in multimorbid diabetic inpatients with a broad spectrum of cardiovascular disease.

Pfister R, Tan D, Thekkanal J, Hellmich M, Erdmann E, Schneider CA. Pfister R, et al. Among authors: schneider ca. Acta Diabetol. 2007 Jun;44(2):91-7. doi: 10.1007/s00592-007-0248-4. Epub 2007 May 27. Acta Diabetol. 2007. PMID: 17530473

6

Delta-glycated hemoglobin: a novel independent risk factor for cardiovascular events in patients without diabetes mellitus.

Diedrichs H, Pfister R, Clement Z, Hagemeister J, Schneider CA. Diedrichs H, et al. Among authors: schneider ca. J Endocrinol Invest. 2009 Jul;32(7):564-7. doi: 10.1007/BF03346509. Epub 2009 Jun 15. J Endocrinol Invest. 2009. PMID: 19535894

7

NT-pro-BNP predicts worsening renal function in patients with chronic systolic heart failure.

Pfister R, Müller-Ehmsen J, Hagemeister J, Hellmich M, Erdmann E, Schneider CA. Pfister R, et al. Among authors: schneider ca. Intern Med J. 2011 Jun;41(6):467-72. doi: 10.1111/j.1445-5994.2010.02203.x. Epub 2010 Feb 26. Intern Med J. 2011. PMID: 20214692

8

Use of NT-proBNP in routine testing and comparison to BNP.

Pfister R, Scholz M, Wielckens K, Erdmann E, Schneider CA. Pfister R, et al. Among authors: schneider ca. Eur J Heart Fail. 2004 Mar 15;6(3):289-93. doi: 10.1016/j.ejheart.2003.12.012. Eur J Heart Fail. 2004. PMID: 14987578 Free article.

9

[Secondary prevention of cardiovascular diseases].

Schneider CA, Erdmann E. Schneider CA, et al. Internist (Berl). 2004 Jun;45 Suppl 1:S23-30. doi: 10.1007/s00108-004-1221-8. Internist (Berl). 2004. PMID: 15148584 German.

10

[Hyperglycemia and cardiovascular events].

Schneider CA, Gallwitz B, Hanefeld M, Leschke M, Müller-Wieland D, Zeymer U, Erdmann E. Schneider CA, et al. Dtsch Med Wochenschr. 2004 Nov 19;129(47):2553-7. doi: 10.1055/s-2004-835301. Dtsch Med Wochenschr. 2004. PMID: 15543474 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

110 results

Search Page